NCT04908176: A Drug-drug Interaction Study of Avapritinib and Midazolam |
|
|
| Active, not recruiting | 1 | 10 | US | Avapritinib, BLU-285, midazolam | Blueprint Medicines Corporation | Gastrointestinal Stromal Tumors, GIST, Non-resectable Advanced Solid Tumors, Recurrent or Unresectable Central Nervous System (CNS) Tumors | 03/24 | 09/25 | | |
NCT06327685: Avapritinib With Decitabine in Patients With SM-AHN |
|
|
| Recruiting | 1 | 34 | US | Avapritinib, Ayvakit, Decitabine, Dacogen, Decitabine/Cedazuridine, Inqovi | H. Lee Moffitt Cancer Center and Research Institute, Blueprint Medicines Corporation | Systemic Mastocytosis With an Associated Hematologic Neoplasm | 03/27 | 03/27 | | |
